Your browser doesn't support javascript.
loading
Decreased frequency of a novel T-lymphocyte subset, CD3+ CD4- CD7+ CD57- T cells, in hepatitis B virus-related end-stage liver disease might contribute to disease progression.
Yu, Xueping; Zheng, Yijuan; Zeng, Dawu; Zhou, Yongjun; Sun, Jian; Su, Milong; Zhang, Huatang; Zheng, Minhui; Huang, Zhipeng; Lin, Wenwu; Mao, Richeng; Zhang, Jiming; Zheng, Chunfu; Su, Zhijun.
Afiliación
  • Yu X; Department of Infectious Diseases, Fujian Medical University Affiliated First Quanzhou Hospital, Quanzhou, China.
  • Zheng Y; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Zeng D; Department of Infectious Diseases, Fujian Medical University Affiliated First Quanzhou Hospital, Quanzhou, China.
  • Zhou Y; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Sun J; Department of Liver Center, The First Hospital Affiliated to Fujian Medical University, Fuzhou, China.
  • Su M; Institute of Bioengineering and Biotechnology, College of Life Sciences and Chemistry, Minnan Science and Technology University, Quanzhou, China.
  • Zhang H; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Zheng M; Department of Infectious Diseases, The First Hospital Affiliated to Wannan Medical College, Wuhu, China.
  • Huang Z; Department of Infectious Diseases, Fujian Medical University Affiliated First Quanzhou Hospital, Quanzhou, China.
  • Lin W; Department of Infectious Diseases, Fujian Medical University Affiliated First Quanzhou Hospital, Quanzhou, China.
  • Mao R; Department of Infectious Diseases, Fujian Medical University Affiliated First Quanzhou Hospital, Quanzhou, China.
  • Zhang J; Department of Infectious Diseases, Fujian Medical University Affiliated First Quanzhou Hospital, Quanzhou, China.
  • Zheng C; Department of Infectious Diseases, Fujian Medical University Affiliated First Quanzhou Hospital, Quanzhou, China.
  • Su Z; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
J Med Virol ; 95(1): e28129, 2023 01.
Article en En | MEDLINE | ID: mdl-36068190
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis B Crónica / Enfermedad Hepática en Estado Terminal Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis B Crónica / Enfermedad Hepática en Estado Terminal Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos